Company / Net Income
Insight Molecular Diagnostics Inc. Net Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$60.7M
FY2025
5-year range
-$72.9M / -$27.8M
FY2021-FY2025
Trend
-118.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$73M to -$61M over the past 2 years.
Based on SEC 10-K filings.
-$61M in FY2025.
Improved from -$73M to -$61M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 118.4% year-over-year.
- Peak net income was recorded in FY2020.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$60.7M | -118.4% |
| FY2024 | -$27.8M | +61.9% |
| FY2023 | -$72.9M | -13.7% |
| FY2022 | -$64.1M | -114.1% |
| FY2021 | -$29.9M | -33.5% |
| FY2020 | -$22.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026